CA2295076A1 - New combination of antiasthma medicaments - Google Patents

New combination of antiasthma medicaments Download PDF

Info

Publication number
CA2295076A1
CA2295076A1 CA002295076A CA2295076A CA2295076A1 CA 2295076 A1 CA2295076 A1 CA 2295076A1 CA 002295076 A CA002295076 A CA 002295076A CA 2295076 A CA2295076 A CA 2295076A CA 2295076 A1 CA2295076 A1 CA 2295076A1
Authority
CA
Canada
Prior art keywords
active ingredient
rofleponide
composition
solvate
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002295076A
Other languages
English (en)
French (fr)
Inventor
Jan Trofast
Leif Kallstrom
Bengt Axelsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2295076A1 publication Critical patent/CA2295076A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002295076A 1997-06-27 1998-06-08 New combination of antiasthma medicaments Abandoned CA2295076A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88382397A 1997-06-27 1997-06-27
US08/883,823 1997-06-27
PCT/SE1998/001089 WO1999000134A1 (en) 1997-06-27 1998-06-08 New combination of antiasthma medicaments

Publications (1)

Publication Number Publication Date
CA2295076A1 true CA2295076A1 (en) 1999-01-07

Family

ID=25383399

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002295076A Abandoned CA2295076A1 (en) 1997-06-27 1998-06-08 New combination of antiasthma medicaments

Country Status (16)

Country Link
EP (1) EP1009408A1 (no)
JP (1) JP2002510310A (no)
KR (1) KR20010014162A (no)
AU (1) AU8135098A (no)
BR (1) BR9810452A (no)
CA (1) CA2295076A1 (no)
EE (1) EE9900594A (no)
HU (1) HUP0002533A3 (no)
ID (1) ID24063A (no)
IL (1) IL133597A0 (no)
IS (1) IS5303A (no)
NO (1) NO996438L (no)
PL (1) PL337722A1 (no)
SK (1) SK184799A3 (no)
TR (1) TR199903272T2 (no)
WO (1) WO1999000134A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
SE9900833D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
GB0009607D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
GB0009617D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
WO2004028545A1 (en) * 2002-09-25 2004-04-08 Astrazeneca Ab A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
JP3342484B2 (ja) * 1991-12-18 2002-11-11 アストラ・アクチエボラーグ 新規な配合
SA95160463B1 (ar) * 1994-12-22 2005-10-04 استرا أكتيبولاج مساحيق للاستنشاق
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
SE9603669D0 (sv) * 1996-10-08 1996-10-08 Astra Ab New combination

Also Published As

Publication number Publication date
TR199903272T2 (xx) 2000-08-21
JP2002510310A (ja) 2002-04-02
BR9810452A (pt) 2000-09-05
IS5303A (is) 1999-12-15
AU8135098A (en) 1999-01-19
KR20010014162A (ko) 2001-02-26
NO996438L (no) 2000-02-28
EP1009408A1 (en) 2000-06-21
SK184799A3 (en) 2000-06-12
ID24063A (id) 2000-07-06
HUP0002533A2 (hu) 2000-12-28
PL337722A1 (en) 2000-08-28
IL133597A0 (en) 2001-04-30
NO996438D0 (no) 1999-12-23
WO1999000134A1 (en) 1999-01-07
EE9900594A (et) 2000-08-15
HUP0002533A3 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
AU715319B2 (en) New combination
AU673660C (en) New combination of formoterol and budesonide
US8461211B2 (en) Use for budesonide and formoterol
EP1085877B1 (en) Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma
JP3042867B2 (ja) 呼吸疾患治療薬
EP1007017A1 (en) New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
CA2295076A1 (en) New combination of antiasthma medicaments
WO2000053188A1 (en) New combination of r,r-formoterol and budesonide in a pharmaceutical composition useful for treating respiratory disorders, such as asthma, rhinitis and copd
EP1101493A2 (en) New combination of formoterol and budesonide
MXPA99011676A (en) New combination of antiasthma medicaments
CZ466899A3 (cs) Nová kombinace antiastmatických léčiv
MXPA98004357A (en) New combination
MXPA00011806A (en) Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma

Legal Events

Date Code Title Description
FZDE Discontinued